-
FDA gives full approval to Moderna's COVID-19 vaccine for use in USA
The Xinhua reported, Moderna's COVID-19 vaccine received full approval from the U.S. Food and Drug Administration (FDA) on Monday.
The vaccine, named Spikevax, is approved for use in people ages 18 and older.
The agency said in a statement, Spikevax meets the FDA's rigorous standards for safety, effectiveness and manufacturing quality required for approval.
Acting FDA Commissioner Janet Woodcock said: "While millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated."
Moderna begins trial of omicron-specific vaccine booster
She said: "Today's milestone puts us one step closer to altering the course of this pandemic in the U.S."
Moderna's COVID-19 vaccine is the second one in the United States to receive full approval from the FDA. Pfizer's COVID-19 vaccine, Comirnaty, was fully approved for use in people ages 16 and older in August 2021.
Small businesses in USA 'besieged' amid Omicron surge
Moderna's COVID-19 vaccine has been available under the FDA's emergency use authorization for individuals 18 years of age and older since Dec. 18, 2020.
Source: xinhua
